FSD Pharma HUGE Stock
FSD Pharma Price Chart
FSD Pharma HUGE Financial and Trading Overview
| FSD Pharma stock price | 0.6 USD |
| Previous Close | 1.16 USD |
| Open | 1.14 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.14 - 1.17 USD |
| 52 Week Range | 0.62 - 2.1 USD |
| Volume | 19.49K USD |
| Avg. Volume | 102.26K USD |
| Market Cap | 44.88M USD |
| Beta (5Y Monthly) | 0.992784 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.46 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HUGE Valuation Measures
| Enterprise Value | 36.14M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.153558 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.299 |
Trading Information
FSD Pharma Stock Price History
| Beta (5Y Monthly) | 0.992784 |
| 52-Week Change | 43.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.1 USD |
| 52 Week Low | 0.62 USD |
| 50-Day Moving Average | 1.32 USD |
| 200-Day Moving Average | 1.13 USD |
HUGE Share Statistics
| Avg. Volume (3 month) | 102.26K USD |
| Avg. Daily Volume (10-Days) | 47.95K USD |
| Shares Outstanding | 39.03M |
| Float | 33.1M |
| Short Ratio | 5.74 |
| % Held by Insiders | 15.98% |
| % Held by Institutions | 1.62% |
| Shares Short | 450.86K |
| Short % of Float | 1.35% |
| Short % of Shares Outstanding | 1.15% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:201 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -47.30% |
| Return on Equity (ttm) | -92.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -27829780 USD |
| Net Income Avi to Common (ttm) | -31200360 USD |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.22M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 466.37K USD |
| Total Debt/Equity (mrq) | 2.24 USD |
| Current Ratio (mrq) | 1.248 |
| Book Value Per Share (mrq) | 0.534 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27993980 USD |
| Levered Free Cash Flow (ttm) | -1742097 USD |
Profile of FSD Pharma
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 199 Bay Street |
| ZIP | M5L 1A9 |
| Phone | 416-854-8884 |
| Website | https://www.fsdpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.
Q&A For FSD Pharma Stock
What is a current HUGE stock price?
FSD Pharma HUGE stock price today per share is 0.6 USD.
How to purchase FSD Pharma stock?
You can buy HUGE shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for FSD Pharma?
The stock symbol or ticker of FSD Pharma is HUGE.
Which industry does the FSD Pharma company belong to?
The FSD Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does FSD Pharma have in circulation?
The max supply of FSD Pharma shares is 40.6M.
What is FSD Pharma Price to Earnings Ratio (PE Ratio)?
FSD Pharma PE Ratio is now.
What was FSD Pharma earnings per share over the trailing 12 months (TTM)?
FSD Pharma EPS is -0.46 USD over the trailing 12 months.
Which sector does the FSD Pharma company belong to?
The FSD Pharma sector is Healthcare.
FSD Pharma HUGE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}